排序方式: 共有5条查询结果,搜索用时 812 毫秒
1
1.
RAYMOND ROUDAUT M.D. MARIE-CLAIRE LARTIGUE M.D. JEAN-FRANCOIS DARTIGUES M.D. PASCAL GUILLO M.D. PHILIPPE GOSSE M.D. MODESTE DALLOCCHIO M.D. 《Echocardiography (Mount Kisco, N.Y.)》1993,10(3):289-292
We have reviewed ten prospective studies of bacteremia with transesophageal echocardiography (TEE) in 720 patients. The incidence of TEE related positive culture is low, and general recommendation for antibiotic prophylaxis during TEE is not warranted. 相似文献
2.
YI CAI MIREILLE SICH AGNS BEZIAU MARY M. KLEPPEL MARIE-CLAIRE GUBLER 《The Journal of pathology》1996,179(2):188-196
Focal and segmental glomerulosclerosis (FSGS) is a non-specific scarring process of the glomerulus, initially described in idiopathic nephrotic syndrome. The distribution of types I, III, IV, V, and VI collagen and of the α 1, α 3, α 4, α 5, and α6 chains of type IV collagen was studied by immunohistochemistry in sclerotic lesions of nine nephrotic children. Dual immunofluorescence and high-resolution immunogold labelling were used to determine the precise distribution of the antigens. No changes were detected in normal glomeruli of patients compared with controls. In FSGS, type IV collagen [α 1(IV)2 α2(IV)], and to a lesser degree type VI, accumulates in the two components of the lesion: the enlarged mesangial matrix and the material deposited between the pushed-out podocytes and the α 3– α 5(IV)-positive glomerular basement membrane. Staining for α6(IV) and types I, III, and V collagen was practically negative. These results suggest that the matrix components of the sclerotic lesion are produced solely by glomerular cells. Changes in the relative distribution of type IV collagen chains, characterized by the presence of collagen [α 1(IV)2 α2(IV)] in close contact with the podocytes, strongly suggest a switch in the podocyte programme of collagen synthesis. 相似文献
3.
4.
D. STAMATIADIS MARIE-CLAIRE BULTEAU-PORTOIS IRENE MOWSZOWICZ 《The British journal of dermatology》1988,119(5):627-632
The effects of zinc sulphate and azelaic acid on 5 alpha-reductase activity in human skin were studied using an in vitro assay with 1,2[3H]-testosterone as substrate. When added at concentrations of 3 or 9 mmol/l, zinc was a potent inhibitor of 5 alpha-reductase activity. At high concentrations, zinc could completely inhibit the enzyme activity. Azelaic acid was also a potent inhibitor of 5 alpha-reductase; inhibition was detectable at concentrations as low as 0.2 mmol/l and was complete at 3 mmol/l. An additive effect of the two inhibitors was observed. Vitamin B6 potentiated the inhibitory effect of zinc, but not of azelaic acid, suggesting that two different mechanisms are involved. When the three substances were added together at very low concentrations which had been shown to be ineffective alone, 90% inhibition of 5 alpha-reductase activity was obtained. If this inhibition is confirmed in vivo, zinc sulphate combined with azelaic acid could be an effective agent in the treatment of androgen related pathology of human skin. 相似文献
5.
PHILIPPE GOURLET ANDR VANDERMEERS MARIE-CLAIRE VANDERMEERS-PIRET PHILIPPE DE NEEF PATRICK ROBBERECHT 《Chemical biology & drug design》1996,48(4):391-396
Chimeric peptides were synthesized by adding the C-terminal extension 28-38 of the pituitary adenylate cyclase activating polypeptide (PACAP) to the sequences (1–27), (2–27), (3–27) and (6–27) of VIP. The capacity of these peptides to occupy the selective PACAP- and the non-selective PACAP-VIP receptors and to stimulate adenylate cyclase activity was studied in Chinese hamster ovary (CHO) cells expressing the recombinant receptors. The results were compared to those obtained with VIP and the corresponding VIP fragments. The presence of the (28–38) PACAP extension increased at least 100-fold the VIP- or VIP fragment affinities for the selective PACAP receptor but not for the non-selective PACAP-VIP receptors. Furthermore, on both receptors, the extension increased peptide intrinsic activity: VIP(3–28) was a partial agonist; while VIP(3–27)/PACAP(28–38) was as potent as VIP and was apparently a full agonist; VIP(6–28) had no intrinsic activity, but VIP(6–27)/PACAP(28–38) was a partial agonist. These results suggest: (1) the presence of a specific domain for the (28–38) PACAP sequence on the selective PACAP receptor; and (2) a stabilizing effect of the (28–38) PACAP sequence on the structure of N-terminally truncated VIP. © Munksgaard 1996. 相似文献
1